Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease.
Bergqvist V, Kadivar M, Molin D, Angelison L, Hammarlund P, Olin M, Torp J, Grip O, Nilson S, Hertervig E, Lillienau J, Marsal J.
Bergqvist V, et al. Among authors: kadivar m.
Therap Adv Gastroenterol. 2018 Oct 11;11:1756284818801244. doi: 10.1177/1756284818801244. eCollection 2018.
Therap Adv Gastroenterol. 2018.
PMID: 30344642
Free PMC article.